Pharmacyclics (United States)
In research, Pharmacyclics (United States) stands highest in Medicine (#11,855 of 17,978 worldwide) and Health Sciences (#15,022 of 20,462 worldwide), over all time.
- World rank, all time
- #14,363 of 42,892
- Rank in United States
- #3,136 of 8,685
- Research works
- 229 ▼ 54% vs 2013–17
- Citations
- 11k 46.7 per fractional work
- Top-10% rate
- 19.1% record average 16.5%
- Open access
- 22% world 28%
What is Pharmacyclics (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #11,855 of 17,978 | 23.7% | 123 | |
| Health SciencesDomain | #15,022 of 20,462 | 23.7% | 124 |
Each strip is that field’s whole ranked pool, with the notch where Pharmacyclics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.9×. Every wedge is a field page.
Who are the top researchers at Pharmacyclics (United States)?
Ranked on the composite score, Richard A. Miller, Joseph J. Buggy and Markus F. Renschler lead among researchers whose main affiliation is Pharmacyclics (United States).
- 1 Richard A. Miller United States · #312,524 worldwide 130 citations · 38 works
- 2 Joseph J. Buggy United States · #452,846 worldwide 84 citations · 20 works
- 3 Markus F. Renschler United States · #488,174 worldwide 42 citations · 19 works
- 4 Danelle F. James United States · #1,019,248 worldwide 34 citations · 15 works
- 5 Sriram Balasubramanian United States · #1,204,087 worldwide 37 citations · 18 works
Which keywords describe research at Pharmacyclics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Prognostic Factors, Therapeutic Targets, Chronic Lymphocytic Leukemia, Genomic Aberrations, PET Imaging, Reactive Oxygen Species and Lymphoma.
- HDAC Inhibitors
- Mutation
- Porphyrins
- Photothermal Therapy
- Epigenetic Regulation
- Tumor Targeting
- Fc Receptors
- Therapeutic Antibodies
- Self-Assembly
- Chemotherapy
- Singlet Oxygen
- Clinical Applications
- Cancer Treatment
- Photodynamic Therapy
- Molecular Profiling
- Classification
- Lymphoma
- PET Imaging
- Chronic Lymphocytic Leukemia
- Prognostic Factors
- Rituximab
- Therapeutic Targets
- Genomic Aberrations
- Reactive Oxygen Species
- Nanoparticles
- Genetic Pathogenesis
- Immunotherapy
- Cancer Therapy
- Antimicrobial
- Photosensitizers
- Metal Complexes
- Glycosylation
- Monoclonal Antibodies
- Antibody Engineering
- Gene Expression
- Targeted Therapy
- Fluorescence Imaging
- Phthalocyanines
- Anticancer Agents
- Transcriptional Regulation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Rituximab52▲ 144×3 topics
- Prognostic Factors43▲ 41×10 topics
- Therapeutic Targets37▲ 68×4 topics
- Chronic Lymphocytic Leukemia35▲ 317×1 topic
- Genomic Aberrations35▲ 317×1 topic
- PET Imaging22▲ 45×4 topics
- Reactive Oxygen Species20▲ 17×7 topics
- Lymphoma19▲ 56×3 topics
- Nanoparticles18▲ 5.8×7 topics
- Classification17▲ 21×2 topics
- Genetic Pathogenesis17▲ 124×1 topic
- Molecular Profiling17▲ 63×1 topic
- Immunotherapy17▲ 11×12 topics
- Photodynamic Therapy16▲ 44×3 topics
- Cancer Therapy14▲ 9.8×9 topics
- Cancer Treatment13▲ 22×5 topics
- Antimicrobial10▲ 16×3 topics
- Clinical Applications10▲ 57×2 topics
- Photosensitizers10▲ 176×1 topic
- Singlet Oxygen10▲ 176×1 topic
- Metal Complexes10▲ 24×2 topics
- Chemotherapy8▲ 5.2×12 topics
- Glycosylation8▲ 16×3 topics
- Self-Assembly8▲ 8.7×4 topics
- Monoclonal Antibodies8▲ 24×3 topics
- Therapeutic Antibodies8▲ 26×2 topics
- Antibody Engineering8▲ 33×1 topic
- Fc Receptors8▲ 33×1 topic
- Gene Expression7▲ 5.0×6 topics
- Tumor Targeting7▲ 22×3 topics
- Targeted Therapy6▲ 13×4 topics
- Epigenetic Regulation6▲ 13×3 topics
- Fluorescence Imaging6▲ 24×1 topic
- Photothermal Therapy6▲ 32×1 topic
- Phthalocyanines6▲ 61×1 topic
- Porphyrins6▲ 61×1 topic
- Anticancer Agents6▲ 11×7 topics
- Mutation6▲ 16×3 topics
- Transcriptional Regulation6▲ 10×4 topics
- HDAC Inhibitors6▲ 128×1 topic
Which research topics does Pharmacyclics (United States) publish most on?
By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications and Phagocytosis and Immune Regulation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Lymphocytic Leukemia Research Genetics 3 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
- 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 4 Phagocytosis and Immune Regulation Immunology 0 works
- 5 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 6 HER2/EGFR in Cancer Research Oncology 0 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
- 9 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pharmacyclics (United States)'s research output changed?
Output in 2018–2022 was 54% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sunnyvale
- Fairchild Semiconductor (United States)
- Advanced Micro Devices (United States)
- Yahoo (United States)
- Fujitsu (United States)
- LinkedIn (United States)
- United Microelectronics (United States)
- Juniper Networks (United States)
- Eloret (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.